Sep 13, 2022 / 03:10PM GMT
Terence C. Flynn - Morgan Stanley, Research Division - Equity Analyst
Great. Well, thanks, everybody, for joining us. I'm Terence Flynn, the U.S. pharma analyst here at Morgan Stanley. We're very pleased to be hosting Eli Lilly today. Joining us from the company is Anat Ashkenazi, the company's CFO. Thank you so much, Anat, for being here. It's great to see you in person.
Anat Ashkenazi - Eli Lilly and Company - Senior VP & CFO
Absolutely.
Terence C. Flynn - Morgan Stanley, Research Division - Equity Analyst
Before we get started, for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
Questions and Answers:
Terence C. Flynn - Morgan Stanley, Research Division - Equity AnalystWell, again, obviously, a very